Manufacture and Supply of Dibucaine Ointment (1%)

The contract solicits the manufacture and supply of Dibucaine Ointment USP at a 1% concentration, packaged in 28g collapsible tubes equipped with rectal applicators, intended for external use and in full compliance with USP and FDA cGMP standards. The product must meet all applicable pharmaceutical specifications for quality, safety, and consistency, with packaging designed to ensure proper delivery and patient usability. Production and delivery are subject to strict regulatory adherence, and the supplier is expected to maintain documentation and quality controls that satisfy federal pharmaceutical manufacturing requirements. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is classified as a subcontract within the Department of Defense’s Medical Supply Chain Pharm FSA. The response deadline is July 28, 2026, with the contract set to be awarded following evaluation of submissions received by that date. The place of performance is designated as FPO, ZIP 34089, and the opportunity is accessible through the DIBBS platform at the provided URL. All bidders must ensure their proposals align with the technical specifications and regulatory compliance outlined in the solicitation to be considered for award.